两株同源野外分离株随机传代制备的相似商业化AMPV活疫苗序列不相关
本研究对两株此类疫苗及其 progenitor 野外株#8544进行全共有序列测序,比较显示野外株#8544的致弱与两株衍生疫苗间无共同替换相关,提示经细胞或组织连续传代致弱是随机过程而非追求特定序列。研究中鉴定的明确疫苗标记有助于野外疫苗策略的快速可靠检测。
要点
- 两株同源野外株制备的AMPV活疫苗全序列比较无共同致弱替换。
- 连续传代致弱是随机过程,不旨在实现特定序列。
- 鉴定的疫苗标记可支持野外疫苗的快速可靠检测。
核心结论
- 野外株#8544经随机传代致弱的两株商业化活疫苗之间无共同序列替换。
研究设计与样本
- 对两株商业化AMPV活疫苗及其 progenitor 野外株#8544进行全共有序列测序与比较。
主要发现
- 野外株#8544的致弱与两株衍生疫苗间无共同替换相关。
- 连续传代致弱是随机过程,而非追求特定序列的机制。
临床怎么用
- 研究中鉴定的明确疫苗标记可用于野外疫苗的快速可靠检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since late '80 s Avian metapneumovirus subtype A causes sufficient disease in Europe for commercial companies to have started developing live attenuated vaccines. Here, two of those vaccines were fully consensus sequenced alongside their progenitor field strain (#8544). Sequences comparison shows that the attenuation of field strain #8544 was associated with no common substitutions between the two derived vaccines. This finding suggests that the attenuation of field viruses via serial passage on cell cultures or tissues is the result of a random process, rather than a mechanism aiming to achieve a specific sequence. Furthermore, field vaccination strategies would greatly benefit by the unambiguous vaccine markers identified in this study, enabling a prompt and confident vaccines detection.
引用
- Laconi A, Catelli E, Cecchinato M, et al. Two similar commercial live attenuated AMPV vaccines prepared by random passage of the identical field isolate, have unrelated sequences. Vaccine. 2019. PMID: 31003913. doi:10.1016/j.vaccine.2019.04.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。